Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Suitability of an Infant Formula With Reduced Protein Content Based on a Partial Respectively an Extensive Proteinhydrolysate With and Without Pro- and Prebiotics for the Particular Nutritional Use by Infants.-Extension by 4 Year Follow-up

NCT01143233 is registered in ClinicalTrials.gov with HiPP GmbH & Co. Vertrieb KG as lead sponsor.

NCT NCT01143233
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01143233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Suitability of an Infant Formula With Reduced Protein Content Based on a Partial Respectively an Extensive Proteinhydrolysate With and Without Pro- and Prebiotics for the Particular Nutritional Use by Infants.-Extension by 4 Year Follow-up
Lead sponsor
HiPP GmbH & Co. Vertrieb KG
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2010
Completion date
August 31, 2017
Enrollment
503 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

disturbance of growth